Qiaofa Lu

3.9k total citations
10 papers, 82 citations indexed

About

Qiaofa Lu is a scholar working on Molecular Biology, Infectious Diseases and Nephrology. According to data from OpenAlex, Qiaofa Lu has authored 10 papers receiving a total of 82 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 2 papers in Infectious Diseases and 2 papers in Nephrology. Recurrent topics in Qiaofa Lu's work include Glutathione Transferases and Polymorphisms (2 papers), COVID-19 Clinical Research Studies (2 papers) and Fungal Plant Pathogen Control (1 paper). Qiaofa Lu is often cited by papers focused on Glutathione Transferases and Polymorphisms (2 papers), COVID-19 Clinical Research Studies (2 papers) and Fungal Plant Pathogen Control (1 paper). Qiaofa Lu collaborates with scholars based in China, United States and Canada. Qiaofa Lu's co-authors include Jizhao Li, Robert M. Tanguay, Tao Hai, Ruibo Wang, Chengfeng Xiao, Sheng Chen, Tangchun Wu, Yuanyuan Li, Qiming Wang and Juan Li and has published in prestigious journals such as PLoS ONE, Medicine and Cell Stress and Chaperones.

In The Last Decade

Qiaofa Lu

9 papers receiving 81 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qiaofa Lu China 4 46 16 16 14 10 10 82
А. С. Карунас Russia 6 39 0.8× 7 0.4× 9 0.6× 48 3.4× 4 0.4× 36 109
Jiani Sun China 4 28 0.6× 14 0.9× 18 1.1× 4 0.3× 2 0.2× 7 65
Renée Pang Canada 4 18 0.4× 23 1.4× 17 1.1× 10 0.7× 1 0.1× 8 57
Nurcicek Padem United States 4 18 0.4× 5 0.3× 4 0.3× 54 3.9× 3 0.3× 5 93
Gerardo Heiss United States 3 23 0.5× 10 0.6× 12 0.9× 5 0.5× 7 73
Lucas A. Gillenwater United States 6 73 1.6× 6 0.4× 5 0.3× 23 1.6× 3 0.3× 12 124
Hadas Ityel Israel 4 43 0.9× 29 1.8× 5 0.3× 1 0.1× 4 0.4× 4 111
Olivia M. de Goede Canada 3 65 1.4× 9 0.6× 2 0.1× 5 0.4× 2 0.2× 3 91
Reham Abdou United States 3 44 1.0× 7 0.4× 23 1.6× 5 0.5× 4 72
Yujing Xia United Kingdom 2 34 0.7× 4 0.3× 8 0.5× 3 0.2× 1 0.1× 2 44

Countries citing papers authored by Qiaofa Lu

Since Specialization
Citations

This map shows the geographic impact of Qiaofa Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiaofa Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiaofa Lu more than expected).

Fields of papers citing papers by Qiaofa Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiaofa Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiaofa Lu. The network helps show where Qiaofa Lu may publish in the future.

Co-authorship network of co-authors of Qiaofa Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Qiaofa Lu. A scholar is included among the top collaborators of Qiaofa Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiaofa Lu. Qiaofa Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Yang, Jie, et al.. (2024). Schisandrin B attenuates bleomycin-induced pulmonary fibrosis in mice through AKT-mTOR pathway.. PubMed. 41(3). e2024034–e2024034. 1 indexed citations
2.
Li, Yuanyuan, et al.. (2023). Mendelian randomization study shows a causal effect of asthma on chronic obstructive pulmonary disease risk. PLoS ONE. 18(9). e0291102–e0291102. 8 indexed citations
3.
4.
Su, L. Joseph, Jiahao Zhang, Jie Yang, et al.. (2021). Differential Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on COVID-19. PubMed Central. 3(1). 10–10.
5.
Li, Juan, L. Joseph Su, Jie Yang, et al.. (2020). [Clinical characteristics and risk factors of acute kidney injury in coronavirus disease 2019].. PubMed. 32(4). 407–411. 11 indexed citations
6.
Li, Yuanyuan, Weifeng Shang, Qiaofa Lu, et al.. (2018). Prevalence of pulmonary hypertension in peritoneal dialysis patients: a meta-analysis. International Urology and Nephrology. 51(1). 175–180. 2 indexed citations
7.
Lu, Qiaofa. (2008). Association between susceptibility of lung cancer and genetic polymorphism of GST M1. 1 indexed citations
8.
Wang, Qiming, et al.. (2006). Relationship between CYP2C9 and GST M1 Genetic Polymorphism and Lung Cancer Susceptibility. Zhongliu fangzhi yanjiu. 33(1). 8–10. 3 indexed citations
9.
Lu, Qiaofa, et al.. (2003). [Co-detection of P21, P53 and HSP70 and their possible role in diagnosis of polycyclic aromatic hydrocarbons (PAHs)-related lung cancer].. PubMed. 21(5). 359–61. 3 indexed citations
10.
Xiao, Chengfeng, Sheng Chen, Jizhao Li, et al.. (2002). Association of HSP70 and genotoxic damage in lymphocytes of workers exposed to coke-oven emission. Cell Stress and Chaperones. 7(4). 396–396. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026